✦ LIBER ✦

Lapatinib Distribution in HER2 Overexpressing Experimental Brain Metastases of Breast Cancer

✍ Scribed by Kunal S. Taskar; Vinay Rudraraju; Rajendar K. Mittapalli; Ramakrishna Samala; Helen R. Thorsheim; Julie Lockman; Brunilde Gril; Emily Hua; Diane Palmieri; Joseph W. Polli; Stephen Castellino; Stephen D. Rubin; Paul R. Lockman; Patricia S. Steeg; Quentin R. Smith

Publisher: Springer US
Year: 2011
Tongue: English
Weight: 749 KB
Volume: 29
Category: Article
ISSN: 0724-8741
DOI: 10.1007/s11095-011-0601-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Brain metastases in patients who receive

Brain metastases in patients who receive trastuzumab-containing chemotherapy for HER2-overexpressing metastatic breast cancer

✍ Makiko Ono; Masashi Ando; Mayu Yunokawa; Eriko Nakano; Kan Yonemori; Koji Matsum 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 247 KB

Randomized phase II study of lapatinib p

Randomized phase II study of lapatinib plus capecitabine or lapatinib plus topotecan for patients with HER2-positive breast cancer brain metastases

✍ Nancy U. Lin; Wolfgang Eierman; Richard Greil; Mario Campone; Bella Kaufman; Kla 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 189 KB

Cost-effectiveness analysis of lapatinib

Cost-effectiveness analysis of lapatinib in HER-2–positive advanced breast cancer

✍ Quang A. Le; Joel W. Hay 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 298 KB 👁 2 views

Role of trastuzumab in patients with bra

Role of trastuzumab in patients with brain metastases from Her2 positive breast cancer

✍ Nilufer Bulut; Hakan Harputluoglu; Omer Dizdar; Kadri Altundag 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 84 KB

Survival in patients with brain metastas

Survival in patients with brain metastases from breast cancer : The importance of HER-2 status

✍ April F. Eichler; Irene Kuter; Paula Ryan; Lidia Schapira; Jerry Younger; John W 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 183 KB 👁 2 views

## Abstract ## BACKGROUND Brain metastases (BM) are the most common intracranial tumors in adults. To the authors' knowledge, established prognostic factors for survival after the diagnosis of BM in breast cancer patients do not take into account HER–2 status, which may have increasing relevance i

Trastuzumab prolongs overall survival in

Trastuzumab prolongs overall survival in patients with brain metastases from Her2 positive breast cancer

✍ Rupert Bartsch; Andrea Rottenfusser; Catharina Wenzel; Karin Dieckmann; Ursula P 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 162 KB